Effects of glycyrrhetinic acid on aminonucleoside nephrosis in rats.
The effects of glycyrrhetinic acid (GA), an aglycon of glycyrrhizin extracted from the roots of Glycyrrhizae radix, on puromycin aminonucleoside (PA) nephrosis were studied in rats. Urine protein excretion in female rats (130 g-150 g) receiving PA (50 mg/kg) alone was significantly elevated on the 2nd day after injection of PA and reached a peak on the 14th day. Urinary protein on the 14th day was reduced to 74% in animals treated with GA (20 mg/kg) starting on the 2nd day after injection of PA. The increase in serum cholesterol and the decrease in serum protein were also suppressed by GA. Observation by electron microscopy revealed that the degree of abnormality in glomerular epithelial cells, i.e. loss or fusion of foot processes, was lower in the rats treated with GA after PA injection than in the rat treated with PA alone. Moreover, pretreatment with GA did not suppress urinary protein excretion but when it was given at the same time as PA and after PA a significant decrease in urinary protein excretion was observed.
Guoji
Y
Y
Research Institute of Oriental Medicine, Kinki University, Osaka, Japan.
Orita
M
M
Tashiro
K
K
Abe
H
H
D000818:Animals; D001798:Blood Proteins / Q000187:drug effects; D002784:Cholesterol / Q000097:blood; D004195:Disease Models, Animal; D005260:Female; D006034:Glycyrrhetinic Acid / Q000494:pharmacology*; D007668:Kidney / Q000187:drug effects / Q000473:pathology; D008054:Lipid Peroxides / Q000097:blood; D008854:Microscopy, Electron; D009401:Nephrosis / Q000139:chemically induced / Q000188:drug therapy*; D011507:Proteinuria / Q000188:drug therapy; D011692:Puromycin Aminonucleoside / Q000494:pharmacology; D051381:Rats; D017208:Rats, Wistar
D001798:Blood Proteins; D008054:Lipid Peroxides; D011692:Puromycin Aminonucleoside; D002784:Cholesterol; D006034:Glycyrrhetinic Acid